A systematic review of benzoyl peroxide for acne vulgaris

References

• Brown SK, Shalita AR. Acne vulgaris. Lancet. 1998;20351:1871–1876.
   PubMed Web of Science ®Google Scholar
• Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56:651–663.
   PubMed Web of Science ®Google Scholar
• Dréno B. Recent data on epidemiology of acne. Ann Dermatol Venereol. 2010;137(Suppl 2):S49–S51; French.
   Google Scholar
• Tan JK. Psychosocial impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett. 2004;9:1.
   PubMedGoogle Scholar
• Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. BMJ. 1998;139:846–850.
   Google Scholar
• Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998;134:454–458.
   PubMed Web of Science ®Google Scholar
• Halvorsen JA, Stern RS, Dalgard F, Thoresen M, Bjertness E, Lien L. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study. J Invest Dermatol. 2011;131:363–370.
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(Suppl 1):S1–S50.
   PubMedGoogle Scholar
• Rzany B, Kahl C. Epidemiology of acne vulgaris. J Dtsch Dermatol Ges. 2006;4:8–9; German.
   PubMedGoogle Scholar
• Spencer EH, Ferdowsian HR, Barnard ND. Diet and acne: a review of the evidence. Int J Dermatol. 2009;48:339–347.
   PubMedGoogle Scholar
• Dutil M. Benzoyl peroxide: enhancing antibiotic efficacy in acne management. Skin Therapy Lett. 2010;15:5–7.
   PubMedGoogle Scholar
• Tanghetti EA, Popp KF. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Dermatol Clin. 2009;27:17–24.
   PubMed Web of Science ®Google Scholar
• Russell JJ. Topical therapy for acne. Am Fam Physician. 2000;61:357–366.
   PubMed Web of Science ®Google Scholar
• Handojo I. The combined use of topical benzoyl peroxide and tretinoin in the treatment of acne vulgaris. Int J Dermatol. 1979;18:489–496.
   PubMedGoogle Scholar
• Mesquita-Guimaraes J, Ramos S, Tavares MR, Carvalho MR. A double-blind clinical trial with a lotion containing 5% benzoyl peroxide and 2% miconazole in patients with acne vulgaris. Clin Exp Dermatol. 1989;14:357–360.
   PubMedGoogle Scholar
• Norris JF, Hughes BR, Basey AJ, Cunliffe WJ. A comparison of the effectiveness of topical tetracycline, benzoyl-peroxide gel and oral oxytetracycline in the treatment of acne. Clin Exp Dermatol. 1991;16:31–33.
   PubMedGoogle Scholar
• Lehmann HP, Robinson KA, Andrews JS, Holloway V, Goodman SN. Acne therapy: a methodologic review. J Am Acad Dermatol. 2002;47:231–240.
   PubMed Web of Science ®Google Scholar
• do Nascimento LV, Guedes ACM, Magalhães GM, de Faria FA, Guerra RM, de C Almeida F. Single-blind and comparative clinical study of the efficacy and safety of benzoyl peroxide 4% gel (BID) and adapalene 0.1% Gel (QD) in the treatment of acne vulgaris for 11 weeks. J Dermatolog Treat. 2003;14:166–171.
   PubMedGoogle Scholar
• Waller JM, Dreher F, Behnam S, Ford C, Lee C, Tiet T, et al. ‘Keratolytic’ properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. Skin Pharmacol Physiol. 2006;19:283–289.
   PubMed Web of Science ®Google Scholar
• Mills OH Jr, Kligman AM, Pochi P, Comite H. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris. Int J Dermatol. 1986;25:664–667.
   PubMed Web of Science ®Google Scholar
• Harper JC. Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations. J Drugs Dermatol. 2010;9:482–487.
   PubMedGoogle Scholar
• Worret WI, Fluhr JW. Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. J Dtsch Dermatol Ges. 2006;4:293–300; German.
   PubMedGoogle Scholar
• Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. J Am Acad Dermatol. 2010;63:52–62.
   PubMed Web of Science ®Google Scholar
• Tan JK, Li Y, Fung K, Gupta AK, Thomas DR, Sapra S, et al. Divergence of demographic factors associated with clinical severity compared with quality of life impact in acne. J Cutan Med Surg. 2008;12:235–242.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
   PubMed Web of Science ®Google Scholar
• Belknap BS. Treatment of acne with 5% benzoyl peroxide gel or 0.05% retinoic acid cream. Cutis. 1979;23:856–859.
   PubMedGoogle Scholar
• Lassus A, Juvakoski T, Lauharanta J. Motretinide versus benzoyl peroxide in the treatment of acne vulgaris. Dermatologica. 1984;168:199–201.
   PubMedGoogle Scholar
• Hughes BR, Norris JF, Cunliffe WJ. A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne. Clin Exp Dermatol. 1992;17:165–168.
   PubMedGoogle Scholar
• Langner A, Chu A, Goulden V, Ambroziak M. A randomised, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Br J Dermatol. 2008;158:122–129.
   PubMed Web of Science ®Google Scholar
• Ko HC, Song M, Seo SH, Oh CK, Kwon KS, Kim MB. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability. J Eur Acad Dermatol Venereol. 2009;23:245–250.
   PubMed Web of Science ®Google Scholar
• Swinyer LJ, Baker MD, Swinyer TA, Mills OH. A comparative study of benzoyl peroxide and clindamycin phosphate for treating acne vulgaris. Br J Dermatol. 1988;119:615–622.
   PubMedGoogle Scholar
• Packman AM, Brown RH, Dunlap FE, Kraus SJ, Webster GF. Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion. Int J Dermatol. 1996;35:209–211.
   PubMedGoogle Scholar
• Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clin Ther. 2002;24:1117–1133.
   PubMed Web of Science ®Google Scholar
• Milani M, Bigardi A, Zavattarelli M. Efficacy and safety of stabilised hydrogen peroxide cream (Crystacide) in mild-to-moderate acne vulgaris: a randomised, controlled trial versus benzoyl peroxide gel. Curr Med Res Opin. 2003;19:135–138.
   PubMedGoogle Scholar
• Tirado-Sãnchez A, Ponce-Olivera RM. Efficacy and tolerance of superoxidized solution in the treatment of mild to moderate inflammatory acne. a double-blinded, placebo-controlled, parallel-group, randomized, clinical trial. J Dermatolog Treat. 2009;20:289–292.
   PubMed Web of Science ®Google Scholar
• Hunt MJ, Barnetson RS. A comparative study of gluconolactone versus benzoyl peroxide in the treatment of acne. Australas J Dermatol. 1992;33:131–134.
   PubMed Web of Science ®Google Scholar
• Bissonnette R, Bolduc C, Seite S, Nigen S, Provost N, Maari C, et al. Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris. J Cosmet Dermatol. 2009;8:19–23.
   PubMed Web of Science ®Google Scholar
• Smith EB, Padilla RS, McCabe JM, Becker LE. Benzoyl peroxide lotion (20 percent) in acne. Cutis. 1980;25:90–92.
   PubMedGoogle Scholar
• Papageorgiou PP, Chu AC. Chloroxylenol and zinc oxide containing cream (Nels cream) vs. 5% benzoyl peroxide cream in the treatment of acne vulgaris. A double-blind, randomized, controlled trial. Clin Exp Dermatol. 2000;25:16–20.
   PubMedGoogle Scholar
• Jones T, Mark L, Monroe E, Weiss J, Levy S. A multicentre, double-blind, parallel-group study to evaluate 3% erythromycin/5% benzoyl peroxide dual-pouch pack for acne vulgaris. Clin Drug Investig. 2002;22:455–462.
   Google Scholar
• Boutli F, Zioga M, Koussidou T, Ioannides D, Mourellou O. Comparison of chloroxylenol 0.5% plus salicylic acid 2% cream and benzoyl peroxide 5% gel in the treatment of acne vulgaris: a randomized double-blind study. Drugs Exp Clin Res. 2003;29:101–105.
   PubMedGoogle Scholar
• Marazzi P, Boorman GC, Donald AE, Davies HD. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris. J Dermatolog Treat. 2002;13:111–117.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Lynde CW, Kunynetz RA, Amin S, Choi K, Goldstein E. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. J Cutan Med Surg. 2003;7:31–37.
   PubMed Web of Science ®Google Scholar
• Jackson JM, Fu J-JJ, Almekinder JL. A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris. J Drugs Dermatol. 2010;9:131–136.
   PubMed Web of Science ®Google Scholar
• Chu A, Huber FJ, Plott RT. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Br J Dermatol. 1997;136:235–238.
   PubMedGoogle Scholar
• Langner A, Sheehan-Dare R, Layton A. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris. J Eur Acad Dermatol Venereol. 2007;21:311–319.
   PubMedGoogle Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408–412.
   PubMed Web of Science ®Google Scholar
• Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv. 2008;1:211–217.
   PubMed Web of Science ®Google Scholar
• Schott G, Pachl H, Limbach U, Gundert Remy U, Lieb K, Ludwig WD. The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication. Dtsch Arztebl Int. 2010;107:295–301.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2010;1:100–107.
   PubMedGoogle Scholar
• Kellett N, West F, Finlay AY. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial. Br J Dermatol. 2006;154:524–532.
   PubMed Web of Science ®Google Scholar